Montreal, Canada

Alain Moreau

USPTO Granted Patents = 11 

 

 

Average Co-Inventor Count = 1.5

ph-index = 2

Forward Citations = 8(Granted Patents)


Location History:

  • Montréal, CA (2018 - 2019)
  • Montreal, CA (2011 - 2024)

Company Filing History:


Years Active: 2011-2024

Loading Chart...
Loading Chart...
Loading Chart...
11 patents (USPTO):Explore Patents

Title: Innovations by Alain Moreau

Introduction

Alain Moreau is a notable inventor based in Montreal, Canada. He has made significant contributions to the field of medical technology, particularly in the treatment and diagnosis of scoliosis. With a total of 11 patents to his name, his work has the potential to impact many lives.

Latest Patents

One of his latest patents is a method of treating and prognosing scoliotic patient subgroups. This invention provides a method for classifying subjects into functional groups based on their levels of OPN and treatment options. Another significant patent involves electrified compositions for determining the risk of developing adolescent idiopathic scoliosis. This method focuses on diagnosing predispositions to scoliosis and identifying compounds for treatment through the modulation of Gi protein-coupled receptor activity.

Career Highlights

Throughout his career, Alain Moreau has worked with esteemed institutions such as Chu Sainte-Justine and Hôpital Sainte-Justine. His innovative approaches have garnered attention in the medical community, showcasing his dedication to improving patient outcomes.

Collaborations

Alain has collaborated with several professionals in his field, including Marie-Yvonne Akoume Ndong and Genevieve Mailhot. These partnerships have likely contributed to the advancement of his research and inventions.

Conclusion

Alain Moreau's contributions to medical technology through his patents and collaborations highlight his commitment to innovation in treating scoliosis. His work continues to pave the way for advancements in this important area of healthcare.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…